Monday, February 21, 2005
Aczone (Dapsone) News
Docguide.com has some news on the upcoming Aczone (topical Dapsone) for treatment of acne vulgaris.
Quote:
"In the Phase III efficacy and safety trial reported 496 patients were enrolled. Of those, 330 were treated with 5% dapsone topical gel and 166 with a vehicle control gel. Results from this study demonstrate a significant reduction in the all lesion types (inflammatory, noninflammatory and total lesion counts) in patients using dapsone topical gel compared to the vehicle control group."
Link to the originall article:
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256FAF005250A7
Quote:
"In the Phase III efficacy and safety trial reported 496 patients were enrolled. Of those, 330 were treated with 5% dapsone topical gel and 166 with a vehicle control gel. Results from this study demonstrate a significant reduction in the all lesion types (inflammatory, noninflammatory and total lesion counts) in patients using dapsone topical gel compared to the vehicle control group."
Link to the originall article:
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256FAF005250A7
